XRCC6 and cancer: In cancer cells, SIRT1 inhibition increases Ku70-acetylation, which promotes FLIP (FLICE-like inhibitory protein) downregulation [11], and Ku70-deacetylation stabilizes FLIP and prevents cell death [12].